| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |